Ruminococcus bromii

Optimal result: 14.2 – 17.7 Units

R. bromii increased on a resistant starch diet.

In a study on 360 Spanish adults with different levels of adherence to a Mediterranean diet, legume consumption was shown to enhance R. bromii.

In a population study on 156 asymptomatic Mexican adults, Blastocystis colonization was strongly correlated with an increase in R. bromii.

The abundance of Ruminococcus bromii is associated with faecal butyrate levels and atopic dermatitis in infancy.

A study on 409 type 2 diabetes Chinese patients demonstrated the reduction of R. bromii with berberine. It is thought that the hypoglycemic effect of berberine is mediated by the inhibition of secondary bile acid biotransformation by R. bromii.

R. bromii decreased on a gluten-free diet in 21 healthy volunteers.

A small study on 11 healthy volunteers showed that an animal-based diet increased the abundance of bile-tolerant microorganisms (Alistipes, Bilophila and Bacteroides) and decreased the levels of Firmicutes that metabolize dietary plant polysaccharides (Roseburia, Eubacterium rectale and Ruminococcus bromii).

Oral versus IV iron supplementation in iron deficient IBD patients resulted in decreased abundances of Faecalibacterium prausnitzii, Ruminococcus bromii, Dorea spp., and Collinsella aerofaciens. 

A study on 409 type 2 diabetes Chinese patients demonstrated the reduction of R. bromii with berberine. It is thought that the hypoglycemic effect of berberine is mediated by the inhibition of secondary bile acid biotransformation by R. bromii.

Ruminococcus bromii is a keystone species, playing a large role in the digestion of resistant starches. It has been proposed that the primary role played by R. bromii is to release energy from resistant starch to other members of the microbial community, giving it an important role for maintaining microbial community balance. R. gnavus can efficiently cross-feed on starch degradation products released by R. bromii, even though it is normally a mucin degrading bacteria.

Ruminococcus bromii is a keystone species, playing a large role in the digestion of resistant starches. It has been proposed that the primary role played by R. bromii is to release energy from resistant starch to other members of the microbial community, giving it an important role for maintaining microbial community balance. R. gnavus can efficiently cross-feed on starch degradation products released by R. bromii, even though it is normally a mucin degrading bacteria.

R. bromii ferments resitant starch which is correlated with increased butyrate production downstream. The major fermentation products include acetate, H2, and CO2. The byproducts of the degradation of resistant startch are used by the bacterial species. Therefore, R. bromii supports microbiome diversity through cross-feeding. One study showed that five species, including R. bromii, were significantly more abundant in stool samples from obese individuals versus non-obese individuals. R. bromii is enriched in healthy twins versus those with food allergies. An infant study showed that depletion of R. bromii and Akkermansia muciniphila was associated with reduced butyrate and theh developmenet of atopic dermatitis. 

References:

Ze, X., Duncan, S. H., Louis, P. & Flint, H. J. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon microbe-microbe and microbe-host interactions. ISME J. 6, 1535–1543 (2012).

Crost, E. H. et al. Mechanistic Insights Into the Cross-Feeding of Ruminococcus gnavus and Ruminococcus bromii on Host and Dietary Carbohydrates. Front. Microbiol. 9, (2018).

Sasaki M, Schwab C, Ramirez Garcia A, Li Q, Ferstl R, Bersuch E, Akdis CA, Lauener R; CK-CARE study group; Frei R, Roduit C. The abundance of Ruminococcus bromii is associated with faecal butyrate levels and atopic dermatitis in infancy. Allergy. 2022 Aug 2;77(12):3629–40. doi: 10.1111/all.15440. Epub ahead of print. PMID: 35917214; PMCID: PMC10087690.

Bonder MJ, Tigchelaar EF, Cai X, Trynka G, Cenit MC, Hrdlickova B, Zhong H, Vatanen T, Gevers D, Wijmenga C, Wang Y, Zhernakova A. The influence of a short-term gluten-free diet on the human gut microbiome. Genome Med. 2016 Apr 21;8(1):45. doi: 10.1186/s13073-016-0295-y. PMID: 27102333; PMCID: PMC4841035.

Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. PMID: 26848182; PMCID: PMC5531225.

David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559-63. doi: 10.1038/nature12820. Epub 2013 Dec 11. PMID: 24336217; PMCID: PMC3957428.

Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016 May 3;7(3):189-200. doi: 10.1080/19490976.2015.1134082. Epub 2016 Mar 10. PMID: 26963409; PMCID: PMC4939913.

Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM. Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. mBio. 2019 Jan 29;10(1):e02566-18. doi: 10.1128/mBio.02566-18. PMID: 30696735; PMCID: PMC6355990.

Rangarajan AA, Chia HE, Azaldegui CA, Olszewski MH, Pereira GV, Koropatkin NM, Biteen JS. Ruminococcus bromii enables the growth of proximal Bacteroides thetaiotaomicron by releasing glucose during starch degradation. Microbiology (Reading). 2022 Apr;168(4). doi: 10.1099/mic.0.001180. PMID: 35471195.

Kasai C, Sugimoto K, Moritani I, Tanaka J, Oya Y, Inoue H, Tameda M, Shiraki K, Ito M, Takei Y, Takase K. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 2015 Aug 11;15:100. doi: 10.1186/s12876-015-0330-2. PMID: 26261039; PMCID: PMC4531509.

Bao R, Hesser LA, He Z, Zhou X, Nadeau KC, Nagler CR. Fecal microbiome and metabolome differ in healthy and food-allergic twins. J Clin Invest. 2021 Jan 19;131(2):e141935. doi: 10.1172/JCI141935. PMID: 33463536; PMCID: PMC7810484.

Rosés C, Cuevas-Sierra A, Quintana S, Riezu-Boj JI, Martínez JA, Milagro FI, Barceló A. Gut Microbiota Bacterial Species Associated with Mediterranean Diet-Related Food Groups in a Northern Spanish Population. Nutrients. 2021 Feb 16;13(2):636. doi: 10.3390/nu13020636. PMID: 33669303; PMCID: PMC7920039.

Nieves-Ramírez ME, Partida-Rodríguez O, Laforest-Lapointe I, Reynolds LA, Brown EM, Valdez-Salazar A, Morán-Silva P, Rojas-Velázquez L, Morien E, Parfrey LW, Jin M, Walter J, Torres J, Arrieta MC, Ximénez-García C, Finlay BB. Asymptomatic Intestinal Colonization with Protist Blastocystis Is Strongly Associated with Distinct Microbiome Ecological Patterns. mSystems. 2018 Jun 26;3(3):e00007-18. doi: 10.1128/mSystems.00007-18. PMID: 29963639; PMCID: PMC6020473.

Zhang Y, Gu Y, Ren H, Wang S, Zhong H, Zhao X, Ma J, Gu X, Xue Y, Huang S, Yang J, Chen L, Chen G, Qu S, Liang J, Qin L, Huang Q, Peng Y, Li Q, Wang X, Kong P, Hou G, Gao M, Shi Z, Li X, Qiu Y, Zou Y, Yang H, Wang J, Xu G, Lai S, Li J, Ning G, Wang W. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020 Oct 6;11(1):5015. doi: 10.1038/s41467-020-18414-8. PMID: 33024120; PMCID: PMC7538905.

Ruminococcus bromii
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Ruminococcus bromii — 10,000+ markers explained
One Ruminococcus bromii result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro